GE HealthCare has delivered the initial subject doses of a positron emission tomography (PET) myocardial perfusion imaging ...
Alzheimer's disease, a type of dementia that profoundly alters a person’s memory and cognitive function, affects an estimated ...
Early detection of Alzheimer’s disease (AD) can improve treatment outcomes, but current testing methods still have ...
Positron Corporation (OTC: POSC), a leading molecular imaging medical device company specializing in PET and PET-CT imaging systems and clinical support services, is pleased to announce it has entered ...
Cardiac sarcoidosis (CS) was a complication in about 10% of pulmonary sarcoidosis (PS) cases, investigators reported in Respiratory Medicine. The retrospective study assessed the prevalence, incidence ...
Market Growth Is Driven by Technological Innovations and An Increasing Incidence of Chronic Diseases.Pune, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Global Positron Emission Tomography Market Size & Growth ...
GE HealthCare (GEHC) has delivered the first patient doses of Flyrcado or flurpiridaz F 18 njection, a first-of-its-kind unit dose positron ...
Neurofilament light (NFL) is a powerful and sensitive biomarker for tracking neuronal health and disease progression.
A discovery of how to target mutated proteins in tumors made a decade ago never matured into a surefire way of destroying ...
Researchers indicate that the Lumipulse p-tau217 assay may reduce over 50% of lumbar punctures performed for diagnosing ...